Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$9.42 -2.0%	$7.89	$5.00 ▼ $16.85	$551.18M	1.25	1.43 million shs	7.04 million shs
GSC Goldman Sachs Small Cap Core Equity ETF	$50.53 +0.2%	$48.25	$40.49 ▼ $56.70	$141.48M	1.29	24,609 shs	13,361 shs
KOR Corvus Gold	$3.21	$3.23	$1.71 ▼ $3.30	$407.68M	N/A	174,024 shs	14,560 shs
MAI MainstreamBPO		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	0.00%	+10.36%	+35.30%	+65.07%	-29.58%
GSC Goldman Sachs Small Cap Core Equity ETF	0.00%	+3.35%	+3.95%	+8.39%	+38.44%
KOR Corvus Gold	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DNA Ginkgo Bioworks	0.7913 of 5 stars	0.8	2.0	0.0	0.0	1.8	2.5	1.3
GSC Goldman Sachs Small Cap Core Equity ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MAI MainstreamBPO	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNA Ginkgo Bioworks	1.67	Reduce	$5.77	-38.76% Downside
GSC Goldman Sachs Small Cap Core Equity ETF	2.70	Moderate Buy	$50.53	N/A
KOR Corvus Gold	0.00	N/A	N/A	N/A
MAI MainstreamBPO	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNA Ginkgo Bioworks	$227.04M	2.43	N/A	N/A	$13.17 per share	0.72
GSC Goldman Sachs Small Cap Core Equity ETF	N/A	N/A	N/A	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A	N/A
MAI MainstreamBPO	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNA Ginkgo Bioworks	-$547.03M	-$9.16	N/A	N/A	N/A	-198.84%	-52.35%	-27.14%	8/14/2025 (Estimated)
GSC Goldman Sachs Small Cap Core Equity ETF	N/A	N/A	20.07	∞	N/A	N/A	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MAI MainstreamBPO	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest MAI, GSC, KOR, and DNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/6/2025	Q1 2025	DNA Ginkgo Bioworks	-$1.23	-$1.58	-$0.35	-$1.68	$38.70 million	$48.32 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
GSC Goldman Sachs Small Cap Core Equity ETF	$0.34	0.67%	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	N/A	N/A	N/A
MAI MainstreamBPO	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNA Ginkgo Bioworks	N/A	4.88	4.88
GSC Goldman Sachs Small Cap Core Equity ETF	N/A	N/A	N/A
KOR Corvus Gold	N/A	N/A	N/A
MAI MainstreamBPO	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DNA Ginkgo Bioworks	78.63%
GSC Goldman Sachs Small Cap Core Equity ETF	N/A
KOR Corvus Gold	N/A
MAI MainstreamBPO	N/A

Insider Ownership

Company	Insider Ownership
DNA Ginkgo Bioworks	9.72%
GSC Goldman Sachs Small Cap Core Equity ETF	N/A
KOR Corvus Gold	N/A
MAI MainstreamBPO	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DNA Ginkgo Bioworks	640	58.53 million	52.84 million	Optionable
GSC Goldman Sachs Small Cap Core Equity ETF	N/A	2.80 million	N/A	Not Optionable
KOR Corvus Gold	N/A	127.00 million	N/A	Not Optionable
MAI MainstreamBPO	147,000	N/A	N/A	Not Optionable

MAI, GSC, KOR, and DNA Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

D-Wave Goes International With South Korea Partnership
By Nathan Reiff | June 23, 2025
View D-Wave Goes International With South Korea Partnership
Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern
By Leo Miller | June 2, 2025
View Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern
Is CrowdStrike Stock Set to Break Out or Cool Off?
By Chris Markoch | June 17, 2025
View Is CrowdStrike Stock Set to Break Out or Cool Off?
Alphabet Stock Analysis: What's Next—Bull or Bear Market?
By Ryan Hasson | June 5, 2025
View Alphabet Stock Analysis: What's Next—Bull or Bear Market?
2 Reasons Adobe Stock Is Ready to Rally This Year
By Thomas Hughes | June 16, 2025
View 2 Reasons Adobe Stock Is Ready to Rally This Year

MAI, GSC, KOR, and DNA Company Descriptions

Ginkgo Bioworks NYSE:DNA

$9.42 -0.19 (-2.01%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$9.38 -0.04 (-0.39%)

As of 06/27/2025 07:38 PM Eastern

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Goldman Sachs Small Cap Core Equity ETF NYSEARCA:GSC

$50.53 +0.12 (+0.24%)

As of 06/27/2025 04:10 PM Eastern

The Goldman Sachs Small Cap Core Equity ETF (GSC) is an exchange-traded fund that mostly invests in small-cap stocks. The fund is an actively managed ETF that invests in small-cap companies. The fund tilts towards US companies but may still invest in securities from other countries, including emerging markets. GSC was launched on Oct 3, 2023 and is issued by Goldman Sachs.

Corvus Gold NYSE:KOR

Corvus Gold is a junior exploration and development gold company led by an experienced management team that holds a large equity stake. The Company's main focus and efforts is in the advancement of its 100% owned North Bullfrog project - a new Nevada gold discovery.

MainstreamBPO NYSE:MAI

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time